Study on the Development of Arthroscopic Treatment of Refractory Tennis Elbow
1 other identifier
observational
43
1 country
1
Brief Summary
The aim of this study was to investigate the exploration history, key theories, methods, and techniques involved in the evolution from the intracapsular method to the extracapsular method for arthroscopic treatment of tennis elbow, and explore the effectiveness and safety of extracapsular method on the basis of retrospective analysis of 43 cases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 23, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 23, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 2, 2019
CompletedFirst Submitted
Initial submission to the registry
June 26, 2020
CompletedFirst Posted
Study publicly available on registry
July 1, 2020
CompletedJuly 1, 2020
June 1, 2020
6 months
June 26, 2020
June 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Mayo Elbow Performance Score
Use Mayo Elbow Performance Score(MEPS) to evaluate the functional recovery of patients who received extracapsular arthroscopic treatment. MEPS ranges from 0 to 100, higher scores mean a better outcome.
12 months
Visual Analog Scale
Use Visual Analog Scale(VAS) to evaluate the pain recovery of patients who received extracapsular arthroscopic treatment. VAS ranges from 0 to 10, higher scores mean a worse outcome.
12 months
Disability of Arm, Shoulder and Hand score
Use Disability of Arm, Shoulder and Hand(DASH) score to evaluate the functional and pain recovery of patients who received extracapsular arthroscopic treatment. DASH ranges from 0 to 100, higher scores mean a worse outcome.
12 months
Activity of Daily Life recovery time
Use Activity of Daily Life recovery time to evaluate the functional recovery of patients who received extracapsular arthroscopic treatment.
12 months
Study Arms (1)
Extracapsular method group
consecutive 43 patients who received extracapsular method treatment for refractory tennis elbow
Interventions
Extracapsular arthroscopy method was used to treat refractory tennis elbow
Eligibility Criteria
the quantitative data of 43 patients (14 men and 29 women) were reviewed. The minimum age was 35 years, and the maximum age was 55 years old, with an average of 44.4 years.
You may qualify if:
- Diagnosis was refractory tennis elbow;
- Standard extracapsular method was used for surgery.
You may not qualify if:
- Patient had past history of joint infection, joint tuberculosis, or osteomyelitis, or the upper limb had undergone surgery within the past 6 months;
- Diagnosis was combined with severe heart, brain, kidney, or another organ dysfunction;
- Case was complicated with other serious elbow joint diseases or injuries;
- Patient did not sign the informed consent form.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking Univerisity Third Hospital
Beijing, Beijing Municipality, 100191, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2020
First Posted
July 1, 2020
Study Start
May 23, 2018
Primary Completion
November 23, 2018
Study Completion
May 2, 2019
Last Updated
July 1, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share